Copyright Reports & Markets. All rights reserved.

Global Artemisinin API Market Research Report 2021

Request for Sample of this report
Buy now

1 Artemisinin API Market Overview

  • 1.1 Product Overview and Scope of Artemisinin API
  • 1.2 Artemisinin API Segment by Type
    • 1.2.1 Global Artemisinin API Market Size Growth Rate Analysis by Type 2021 VS 2027
    • 1.2.2 Extraction from Artemisia annua
    • 1.2.3 Semisynthetic Artemisinin
  • 1.3 Artemisinin API Segment by Application
    • 1.3.1 Global Artemisinin API Consumption Comparison by Application: 2016 VS 2021 VS 2027
    • 1.3.2 Antimalarial Injections
    • 1.3.3 Antimalarial Tablets
  • 1.4 Global Market Growth Prospects
    • 1.4.1 Global Artemisinin API Revenue Estimates and Forecasts (2016-2027)
    • 1.4.2 Global Artemisinin API Production Capacity Estimates and Forecasts (2016-2027)
    • 1.4.3 Global Artemisinin API Production Estimates and Forecasts (2016-2027)
  • 1.5 Global Market Size by Region
    • 1.5.1 Global Artemisinin API Market Size Estimates and Forecasts by Region: 2016 VS 2021 VS 2027
    • 1.5.2 North America Artemisinin API Estimates and Forecasts (2016-2027)
    • 1.5.3 Europe Artemisinin API Estimates and Forecasts (2016-2027)
    • 1.5.4 China Artemisinin API Estimates and Forecasts (2016-2027)
    • 1.5.5 Japan Artemisinin API Estimates and Forecasts (2016-2027)

2 Market Competition by Manufacturers

  • 2.1 Global Artemisinin API Production Capacity Market Share by Manufacturers (2016-2021)
  • 2.2 Global Artemisinin API Revenue Market Share by Manufacturers (2016-2021)
  • 2.3 Artemisinin API Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 2.4 Global Artemisinin API Average Price by Manufacturers (2016-2021)
  • 2.5 Manufacturers Artemisinin API Production Sites, Area Served, Product Types
  • 2.6 Artemisinin API Market Competitive Situation and Trends
    • 2.6.1 Artemisinin API Market Concentration Rate
    • 2.6.2 Global 5 and 10 Largest Artemisinin API Players Market Share by Revenue
    • 2.6.3 Mergers & Acquisitions, Expansion

3 Production and Capacity by Region

  • 3.1 Global Production Capacity of Artemisinin API Market Share by Region (2016-2021)
  • 3.2 Global Artemisinin API Revenue Market Share by Region (2016-2021)
  • 3.3 Global Artemisinin API Production Capacity, Revenue, Price and Gross Margin (2016-2021)
  • 3.4 North America Artemisinin API Production
    • 3.4.1 North America Artemisinin API Production Growth Rate (2016-2021)
    • 3.4.2 North America Artemisinin API Production Capacity, Revenue, Price and Gross Margin (2016-2021)
  • 3.5 Europe Artemisinin API Production
    • 3.5.1 Europe Artemisinin API Production Growth Rate (2016-2021)
    • 3.5.2 Europe Artemisinin API Production Capacity, Revenue, Price and Gross Margin (2016-2021)
  • 3.6 China Artemisinin API Production
    • 3.6.1 China Artemisinin API Production Growth Rate (2016-2021)
    • 3.6.2 China Artemisinin API Production Capacity, Revenue, Price and Gross Margin (2016-2021)
  • 3.7 Japan Artemisinin API Production
    • 3.7.1 Japan Artemisinin API Production Growth Rate (2016-2021)
    • 3.7.2 Japan Artemisinin API Production Capacity, Revenue, Price and Gross Margin (2016-2021)

4 Global Artemisinin API Consumption by Region

  • 4.1 Global Artemisinin API Consumption by Region
    • 4.1.1 Global Artemisinin API Consumption by Region
    • 4.1.2 Global Artemisinin API Consumption Market Share by Region
  • 4.2 North America
    • 4.2.1 North America Artemisinin API Consumption by Country
    • 4.2.2 United States
    • 4.2.3 Canada
  • 4.3 Europe
    • 4.3.1 Europe Artemisinin API Consumption by Country
    • 4.3.2 Germany
    • 4.3.3 France
    • 4.3.4 U.K.
    • 4.3.5 Italy
    • 4.3.6 Russia
  • 4.4 Asia Pacific
    • 4.4.1 Asia Pacific Artemisinin API Consumption by Region
    • 4.4.2 China
    • 4.4.3 Japan
    • 4.4.4 South Korea
    • 4.4.5 Taiwan
    • 4.4.6 Southeast Asia
    • 4.4.7 India
    • 4.4.8 Australia
  • 4.5 Latin America
    • 4.5.1 Latin America Artemisinin API Consumption by Country
    • 4.5.2 Mexico
    • 4.5.3 Brazil

5 Production, Revenue, Price Trend by Type

  • 5.1 Global Artemisinin API Production Market Share by Type (2016-2021)
  • 5.2 Global Artemisinin API Revenue Market Share by Type (2016-2021)
  • 5.3 Global Artemisinin API Price by Type (2016-2021)

6 Consumption Analysis by Application

  • 6.1 Global Artemisinin API Consumption Market Share by Application (2016-2021)
  • 6.2 Global Artemisinin API Consumption Growth Rate by Application (2016-2021)

7 Key Companies Profiled

  • 7.1 Sanofi
    • 7.1.1 Sanofi Artemisinin API Corporation Information
    • 7.1.2 Sanofi Artemisinin API Product Portfolio
    • 7.1.3 Sanofi Artemisinin API Production Capacity, Revenue, Price and Gross Margin (2016-2021)
    • 7.1.4 Sanofi Main Business and Markets Served
    • 7.1.5 Sanofi Recent Developments/Updates
  • 7.2 KPC Pharmaceuticals
    • 7.2.1 KPC Pharmaceuticals Artemisinin API Corporation Information
    • 7.2.2 KPC Pharmaceuticals Artemisinin API Product Portfolio
    • 7.2.3 KPC Pharmaceuticals Artemisinin API Production Capacity, Revenue, Price and Gross Margin (2016-2021)
    • 7.2.4 KPC Pharmaceuticals Main Business and Markets Served
    • 7.2.5 KPC Pharmaceuticals Recent Developments/Updates
  • 7.3 Kerui nanhai
    • 7.3.1 Kerui nanhai Artemisinin API Corporation Information
    • 7.3.2 Kerui nanhai Artemisinin API Product Portfolio
    • 7.3.3 Kerui nanhai Artemisinin API Production Capacity, Revenue, Price and Gross Margin (2016-2021)
    • 7.3.4 Kerui nanhai Main Business and Markets Served
    • 7.3.5 Kerui nanhai Recent Developments/Updates
  • 7.4 Guangxi xiancaotang
    • 7.4.1 Guangxi xiancaotang Artemisinin API Corporation Information
    • 7.4.2 Guangxi xiancaotang Artemisinin API Product Portfolio
    • 7.4.3 Guangxi xiancaotang Artemisinin API Production Capacity, Revenue, Price and Gross Margin (2016-2021)
    • 7.4.4 Guangxi xiancaotang Main Business and Markets Served
    • 7.4.5 Guangxi xiancaotang Recent Developments/Updates
  • 7.5 Guilin Pharmaceutical
    • 7.5.1 Guilin Pharmaceutical Artemisinin API Corporation Information
    • 7.5.2 Guilin Pharmaceutical Artemisinin API Product Portfolio
    • 7.5.3 Guilin Pharmaceutical Artemisinin API Production Capacity, Revenue, Price and Gross Margin (2016-2021)
    • 7.5.4 Guilin Pharmaceutical Main Business and Markets Served
    • 7.5.5 Guilin Pharmaceutical Recent Developments/Updates
  • 7.6 Natural Bio-engineering
    • 7.6.1 Natural Bio-engineering Artemisinin API Corporation Information
    • 7.6.2 Natural Bio-engineering Artemisinin API Product Portfolio
    • 7.6.3 Natural Bio-engineering Artemisinin API Production Capacity, Revenue, Price and Gross Margin (2016-2021)
    • 7.6.4 Natural Bio-engineering Main Business and Markets Served
    • 7.6.5 Natural Bio-engineering Recent Developments/Updates
  • 7.7 BIONEXX
    • 7.7.1 BIONEXX Artemisinin API Corporation Information
    • 7.7.2 BIONEXX Artemisinin API Product Portfolio
    • 7.7.3 BIONEXX Artemisinin API Production Capacity, Revenue, Price and Gross Margin (2016-2021)
    • 7.7.4 BIONEXX Main Business and Markets Served
    • 7.7.5 BIONEXX Recent Developments/Updates
  • 7.8 CAT KHANH
    • 7.8.1 CAT KHANH Artemisinin API Corporation Information
    • 7.8.2 CAT KHANH Artemisinin API Product Portfolio
    • 7.8.3 CAT KHANH Artemisinin API Production Capacity, Revenue, Price and Gross Margin (2016-2021)
    • 7.8.4 CAT KHANH Main Business and Markets Served
    • 7.7.5 CAT KHANH Recent Developments/Updates
  • 7.9 BEEPZ
    • 7.9.1 BEEPZ Artemisinin API Corporation Information
    • 7.9.2 BEEPZ Artemisinin API Product Portfolio
    • 7.9.3 BEEPZ Artemisinin API Production Capacity, Revenue, Price and Gross Margin (2016-2021)
    • 7.9.4 BEEPZ Main Business and Markets Served
    • 7.9.5 BEEPZ Recent Developments/Updates
  • 7.10 Novanat Bioresource
    • 7.10.1 Novanat Bioresource Artemisinin API Corporation Information
    • 7.10.2 Novanat Bioresource Artemisinin API Product Portfolio
    • 7.10.3 Novanat Bioresource Artemisinin API Production Capacity, Revenue, Price and Gross Margin (2016-2021)
    • 7.10.4 Novanat Bioresource Main Business and Markets Served
    • 7.10.5 Novanat Bioresource Recent Developments/Updates

8 Artemisinin API Manufacturing Cost Analysis

  • 8.1 Artemisinin API Key Raw Materials Analysis
    • 8.1.1 Key Raw Materials
    • 8.1.2 Key Raw Materials Price Trend
    • 8.1.3 Key Suppliers of Raw Materials
  • 8.2 Proportion of Manufacturing Cost Structure
  • 8.3 Manufacturing Process Analysis of Artemisinin API
  • 8.4 Artemisinin API Industrial Chain Analysis

9 Marketing Channel, Distributors and Customers

  • 9.1 Marketing Channel
  • 9.2 Artemisinin API Distributors List
  • 9.3 Artemisinin API Customers

10 Market Dynamics

  • 10.1 Artemisinin API Industry Trends
  • 10.2 Artemisinin API Growth Drivers
  • 10.3 Artemisinin API Market Challenges
  • 10.4 Artemisinin API Market Restraints

11 Production and Supply Forecast

  • 11.1 Global Forecasted Production of Artemisinin API by Region (2022-2027)
  • 11.2 North America Artemisinin API Production, Revenue Forecast (2022-2027)
  • 11.3 Europe Artemisinin API Production, Revenue Forecast (2022-2027)
  • 11.4 China Artemisinin API Production, Revenue Forecast (2022-2027)
  • 11.5 Japan Artemisinin API Production, Revenue Forecast (2022-2027)

12 Consumption and Demand Forecast

  • 12.1 Global Forecasted Demand Analysis of Artemisinin API
  • 12.2 North America Forecasted Consumption of Artemisinin API by Country
  • 12.3 Europe Market Forecasted Consumption of Artemisinin API by Country
  • 12.4 Asia Pacific Market Forecasted Consumption of Artemisinin API by Region
  • 12.5 Latin America Forecasted Consumption of Artemisinin API by Country

13 Forecast by Type and by Application (2022-2027)

  • 13.1 Global Production, Revenue and Price Forecast by Type (2022-2027)
    • 13.1.1 Global Forecasted Production of Artemisinin API by Type (2022-2027)
    • 13.1.2 Global Forecasted Revenue of Artemisinin API by Type (2022-2027)
    • 13.1.3 Global Forecasted Price of Artemisinin API by Type (2022-2027)
  • 13.2 Global Forecasted Consumption of Artemisinin API by Application (2022-2027)

14 Research Finding and Conclusion

    15 Methodology and Data Source

    • 15.1 Methodology/Research Approach
      • 15.1.1 Research Programs/Design
      • 15.1.2 Market Size Estimation
      • 15.1.3 Market Breakdown and Data Triangulation
    • 15.2 Data Source
      • 15.2.1 Secondary Sources
      • 15.2.2 Primary Sources
    • 15.3 Author List

    The research report includes specific segments by region (country), by manufacturers, by Type and by Application. Each type provides information about the production during the forecast period of 2016 to 2027. by Application segment also provides consumption during the forecast period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

    Segment by Type
    Extraction from Artemisia annua
    Semisynthetic Artemisinin

    Segment by Application
    Antimalarial Injections
    Antimalarial Tablets

    By Company
    Sanofi
    KPC Pharmaceuticals
    Kerui nanhai
    Guangxi xiancaotang
    Guilin Pharmaceutical
    Natural Bio-engineering
    BIONEXX
    CAT KHANH
    BEEPZ
    Novanat Bioresource

    Production by Region
    North America
    Europe
    China
    Japan

    Consumption by Region
    North America
    United States
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Asia-Pacific
    China
    Japan
    South Korea
    India
    Australia
    China Taiwan
    Indonesia
    Thailand
    Malaysia
    Latin America
    Mexico
    Brazil
    Argentina
    Colombia
    Middle East & Africa
    Turkey
    Saudi Arabia
    UAE

    Buy now